Literature DB >> 20614485

Functional magnetic resonance imaging in an animal model of pancreatic cancer.

Robert J Lewandowski1, Aaron C Eifler, David J Bentrem, Johnathan C Chung, Dingxin Wang, Gayle E Woloschak, Guang-Yu Yang, Robert Ryu, Riad Salem, Andrew-C Larson, Reed-A Omary.   

Abstract

AIM: To test the hypotheses that diffusion weighed (DW)- and transcatheter intraarterial perfusion (TRIP)-magnetic resonance imaging (MRI) can each be used to assess regional differences in tumor function in an animal pancreatic cancer model.
METHODS: VX2 tumors were implanted in pancreata of 6 rabbits. MRI and digital subtraction angiography (DSA) were performed 3 wk following implantation. With a 2-French catheter secured in the rabbit's gastroduodenal artery, each rabbit was transferred to an adjacent 1.5T MRI scanner. DW- and TRIP-MRI were performed to determine if necrotic tumor core could be differentiated from viable tumor periphery. For each, we compared mean differences between tumor core/periphery using a 2-tailed paired t-test (alpha = 0.05). Imaging was correlated with histopathology.
RESULTS: Tumors were successfully grown in all rabbits, confirmed by necropsy. On DW-MRI, mean apparent diffusion coefficient (ADC) value was higher in necrotic tumor core (2.1 +/- 0.3 mm(2)/s) than in viable tumor periphery (1.4 +/- 0.5 mm(2)/s) (P < 0.05). On TRIP-MRI, mean perfusion values was higher in tumor periphery (110 +/- 47 relative units) than in tumor core (66 +/- 31 relative units) (P < 0.001).
CONCLUSION: Functional MRI can be used to differentiate necrotic from viable tumor cells in an animal pancreatic cancer model using ADC (DW-MRI) and perfusion (TRIP-MRI) values.

Entities:  

Mesh:

Year:  2010        PMID: 20614485      PMCID: PMC2900721          DOI: 10.3748/wjg.v16.i26.3292

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  39 in total

1.  THE ARTERIAL SUPPLY TO EXPERIMENTAL METASTATIC VX2 AND XY TUMORS IN RABBIT LUNGS.

Authors:  R W OGILVIE; J D BLANDING; M L WOOD; W H KNISELY
Journal:  Cancer Res       Date:  1964-09       Impact factor: 12.701

2.  Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry.

Authors:  M Carpelan-Holmström; S Nordling; E Pukkala; R Sankila; J Lüttges; G Klöppel; C Haglund
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

Review 3.  MR imaging of the pancreas.

Authors:  R C Semelka; S M Ascher
Journal:  Radiology       Date:  1993-09       Impact factor: 11.105

4.  Magnetic resonance imaging in an orthotopic rat model: blockade of epidermal growth factor receptor with EMD72000 inhibits human pancreatic carcinoma growth.

Authors:  Christopher Bangard; Axel Gossmann; Armine Papyan; Samir Tawadros; Martin Hellmich; Christiane J Bruns
Journal:  Int J Cancer       Date:  2005-03-10       Impact factor: 7.396

5.  Radio-frequency tissue ablation of VX2 tumor nodules in the rabbit lung.

Authors:  S N Goldberg; G S Gazelle; C C Compton; P R Mueller; T C McLoud
Journal:  Acad Radiol       Date:  1996-11       Impact factor: 3.173

6.  A reproducible model of metastatic brain and ocular tumor by hematogenous inoculation of the VX2 tumor in rabbits.

Authors:  J A Frank; M Girton; A J Dwyer; P J Cohen; R H Knop; R Diggs; J Cobb; J L Doppman
Journal:  J Neurosurg       Date:  1987-07       Impact factor: 5.115

7.  Catheter position for adequate intra-arterial chemotherapy for advanced pancreatic cancer: evaluation with CT during arterial injection of contrast material.

Authors:  Toshihiro Tanaka; Hiroshi Sakaguchi; Hiroshi Anai; Kiyosei Yamamoto; Kengo Morimoto; Hideyuki Nishiofuku; Kimihiko Kichikawa
Journal:  J Vasc Interv Radiol       Date:  2004-10       Impact factor: 3.464

8.  Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability--report of the Radiology Diagnostic Oncology Group.

Authors:  A J Megibow; X H Zhou; H Rotterdam; I R Francis; E A Zerhouni; D M Balfe; J C Weinreb; A Aisen; J Kuhlman; J P Heiken
Journal:  Radiology       Date:  1995-05       Impact factor: 11.105

9.  Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors.

Authors:  K C Conlon; D S Klimstra; M F Brennan
Journal:  Ann Surg       Date:  1996-03       Impact factor: 12.969

Review 10.  Modeling pancreatic cancer in animals to address specific hypotheses.

Authors:  Paul J Grippo; Eric P Sandgren
Journal:  Methods Mol Med       Date:  2005
View more
  2 in total

1.  Accumulation of phase-shift nanoemulsions to enhance MR-guided ultrasound-mediated tumor ablation in vivo.

Authors:  Jonathan A Kopechek; Eunjoo Park; Chang-Sheng Mei; Nathan J McDannold; Tyrone M Porter
Journal:  J Healthc Eng       Date:  2013       Impact factor: 2.682

2.  Evaluation of different b-values in DWI and 1H MRS for pancreatic cancer and pancreatitis: a rabbit model.

Authors:  Liguo Hao; Lijie Liu; Xin Meng; Guanghao Yu; Enbang Li; Hongqian Gu
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.